![]() |
市場調查報告書
商品編碼
1453015
造口設備市場:成長、未來前景、競爭分析,2023-2031 年Insufflation Devices Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031 |
結腸造口設備市場的特點是腹腔鏡手術的進步、肥胖治療需求的增加以及心臟手術應用的擴大。 儘管分銷管道面臨挑戰,但市場仍顯示出韌性和成長潛力。 預計 2024 年至 2032 年,結腸造口設備市場將以 6.7% 的複合年增長率成長。 細分分析顯示,受技術創新和患者人口統計變化的影響,手術偏好和分銷管道趨勢正在改變。 區域商機多樣,競爭趨勢凸顯持續研發的必要性。 隨著造口設備市場進入 2023 年的預測期,利害關係人必須克服挑戰並利用新機遇,以確保全球這個重要醫療保健產業的持續成長。但這種情況不會發生。
腹腔鏡手術技術的進展
腹腔鏡手術技術的進步是推動結腸造口設備市場的關鍵因素。 外科醫生和醫療機構,包括梅奧診所等著名醫療中心,正在擁抱腹腔鏡手術並為其發展做出貢獻。 支持這項推動的證據包括同行評審的研究和醫學期刊,記錄了與腹腔鏡手術相關的患者治療效果的改善和恢復時間的縮短。
減重手術的需求不斷增加
在全球肥胖率上升的背景下,減重手術的需求不斷增加,這是結腸造口設備的主要驅動力。 世界衛生組織 (WHO) 等領先的醫療保健組織強調減重手術在管理肥胖相關健康問題的重要性。 流行病學數據和減重手術的增加證明了這種推動力,凸顯了結腸造口設備在這些手術中的重要作用。
擴大在心臟手術的應用
結腸造口設備越來越多地用於心臟手術,促進了市場成長。 克利夫蘭診所等著名心臟中心將氣腹技術納入其微創心臟手術中。 這項推動得到了臨床證據和同行評審文獻的支持,證明結腸造口設備在提高心臟手術的手術精度和患者預後方面具有積極影響。
零售藥局和其他通路面臨的挑戰
儘管市場整體成長,但結腸造口設備的分銷仍面臨挑戰。 監管限制、特殊儲存要求以及嚴格品質控制的需求等問題都是限制因素。 醫療保健提供者在採購和維護這些專用醫療設備的供應鏈時所面臨的挑戰證明了這個限制。
依應用市場分析:腹腔鏡手術佔據市場主導地位
在細分分析中,應用是影響市場動態的重要因素。 2023年,腹腔鏡手術佔據市場主導地位,收入最高。 然而,在 2024 年至 2032 年的預測期內,減重手術的收入和複合年增長率 (CAGR) 預計將超過腹腔鏡手術。 肥胖盛行率的增加和對肥胖治療介入的接受程度的提高就證明了這種轉變。
依通路劃分的市場分析:零售藥局主導市場
分銷管道是市場區隔的一個重要方面,反映了訪問醫療保健提供者方式的變化。 截至2023年,零售藥局是主要分銷管道,收入最高。 然而,在 2024 年至 2032 年的預測期內,電子商務預計將顯示出最高的收入和預計複合年增長率,這表明分銷格局發生了變化。
北美仍處於世界領先地位
依地區劃分,結腸造口器材市場呈現不同的趨勢。 在醫療基礎設施不斷增加和微創手術技術採用的推動下,預測期內複合年增長率最高的地區預計將是亞太地區。 同時,北美預計將維持其銷售比例最高地區的地位,反映出市場成熟,擁有成熟的醫療器材製造商。
預測期內市場競爭將會加劇
主要公司包括美敦力(Medtronic)、愛惜康(Ethicon)、Karl Storz、奧林巴斯公司(Olympus Corporation)、富士膠卷(Fujifilm)、史賽克(Stryker)、BD、B. Braun Melsungen、施樂輝(Smith & Nephew)、Steris、CONMED 與Richard Wolf。 這些公司透過專注於持續創新、策略合作夥伴關係和滿足醫療保健提供者的獨特需求,在塑造競爭趨勢方面發揮關鍵作用。 整體前景凸顯了該行業對外科技術進步的承諾,並強調了適應不斷變化的市場動態的重要性。
本報告回答的主要問題
The insufflation devices market is characterized by advancements in laparoscopic surgery, the increasing demand for bariatric procedures, and expanding applications in cardiac surgery. Despite challenges in distribution channels, the market demonstrates resilience and potential for growth. The insufflation devices market is expected to grow at a CAGR of 6.7% from 2024 to 2032. The segmentation analysis reveals shifting trends in surgical preferences and distribution channels, influenced by technological innovations and changing patient demographics. Geographically, diverse opportunities present themselves, while competitive trends highlight the need for continuous research and development. As the insufflation devices market progresses from 2023 into the forecast period, stakeholders must navigate challenges and capitalize on emerging opportunities, ensuring the sustained growth of this critical healthcare segment globally.
Advancements in Laparoscopic Surgery Techniques
Advancements in laparoscopic surgery techniques are a major driver propelling the insufflation devices market. Surgeons and healthcare institutions, including renowned medical centers like the Mayo Clinic, have embraced and contributed to the evolution of laparoscopic procedures. Evidence supporting this driver includes peer-reviewed studies and medical journals, showcasing the improved patient outcomes and reduced recovery times associated with laparoscopic surgery.
Increasing Demand in Bariatric Surgery
The increasing demand for bariatric surgery, driven by rising obesity rates globally, is a key driver for insufflation devices. Leading healthcare organizations like the World Health Organization (WHO) emphasize the importance of bariatric surgery in managing obesity-related health issues. This driver is substantiated by epidemiological data and the growing adoption of bariatric procedures, highlighting the indispensable role of insufflation devices in these surgeries.
Expanding Applications in Cardiac Surgery
insufflation devices are finding expanding applications in cardiac surgery, contributing to the market's growth. Notable cardiac centers, such as the Cleveland Clinic, have integrated insufflation technologies in minimally invasive cardiac procedures. This driver is supported by clinical evidence and peer-reviewed articles, illustrating the positive impact of insufflation devices in enhancing surgical precision and patient outcomes in cardiac surgeries.
Challenges in Retail Pharmacies and Other Distribution Channels
Despite the overall market growth, challenges persist in the distribution of insufflation devices. Issues such as regulatory constraints, specialized storage requirements, and the need for stringent quality control pose constraints. This restraint is supported by documented challenges faced by healthcare providers in procuring and maintaining a supply chain for these specialized medical devices.
Market Analysis by Application: Laparoscopic Surgery Dominates the Market
In the segmentation analysis, the application is a critical factor influencing market dynamics. In 2023, laparoscopic surgery dominated the market, generating the highest revenue. However, during the forecast period from 2024 to 2032, bariatric surgery is anticipated to surpass laparoscopic surgery in both revenue and the highest Compound Annual Growth Rate (CAGR). This shift is substantiated by the increasing prevalence of obesity and the growing acceptance of bariatric interventions.
Market Analysis by Distribution Channel: Retail Pharmacies Dominate the Market
The distribution channel is a key aspect of market segmentation, reflecting changes in the way insufflation devices reach healthcare providers. In 2023, retail pharmacies were a primary channel for distribution, contributing the highest revenue. Nevertheless, during the forecast period from 2024 to 2032, e-commerce is expected to exhibit both the highest revenue and the highest CAGR, signaling a transformative shift in the distribution landscape.
North America Remains the Global Leader
Geographically, the insufflation devices market exhibits diverse trends. The region with the highest CAGR during the forecast period is anticipated to be Asia-Pacific, driven by increasing healthcare infrastructure and the adoption of minimally invasive surgical techniques. Meanwhile, North America is expected to maintain its position as the region with the highest revenue percentage, reflecting a mature market with established medical device manufacturers.
Market Competition to Intensify during the Forecast Period
Top players in the insufflation devices market include Medtronic, Ethicon, Karl Storz, Olympus Corporation, Fujifilm, Stryker, BD, B. Braun Melsungen, Smith & Nephew, Steris, CONMED, and Richard Wolf. These companies play a crucial role in shaping competitive trends through continuous innovation, strategic partnerships, and a focus on addressing the unique needs of healthcare providers. The overall outlook emphasizes the industry's commitment to advancing surgical techniques and underscores the importance of adapting to evolving market dynamics.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Insufflation Devices market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report
Micro and macro environment factors that are currently influencing the Insufflation Devices market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Application
End-Use
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Insufflation Devices market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Insufflation Devices market?
Which is the largest regional market for Insufflation Devices market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Insufflation Devices market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Insufflation Devices market worldwide?
FIG. 9Market Positioning of Key Insufflation Devices Market Players, 2023
FIG. 10Global Insufflation Devices Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032